8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cardiovascular205 citations

Zhou H, Xuanyuan X, Lv X, Wang J, Feng K, Chen C, Ma J, Xing D

Bioeffects Seen

Authors not listed · 2023

Share:

Large-scale international trial proves standardized medical protocols can significantly improve stroke patient outcomes and reduce complications.

Plain English Summary

Summary written for general audiences

This large international study tested whether a care bundle protocol for managing blood pressure, blood sugar, fever, and blood clotting could improve outcomes for stroke patients. Researchers found that patients receiving the standardized care bundle had better functional recovery and fewer serious complications compared to usual care.

Why This Matters

While this study focuses on stroke care protocols rather than EMF exposure, it demonstrates the critical importance of rigorous, large-scale clinical trials in establishing effective medical interventions. The research involved over 7,000 patients across 121 hospitals in 10 countries, showing how coordinated international efforts can generate robust evidence for improving patient outcomes. This type of methodological rigor - including blinded endpoints, randomized controlled design, and comprehensive follow-up - represents the gold standard that EMF health research should strive to achieve. The study's success in demonstrating measurable health improvements through systematic protocol implementation underscores why we need similarly designed studies to evaluate EMF exposure effects and potential protective interventions.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2023). Zhou H, Xuanyuan X, Lv X, Wang J, Feng K, Chen C, Ma J, Xing D.
Show BibTeX
@article{zhou_h_xuanyuan_x_lv_x_wang_j_feng_k_chen_c_ma_j_xing_d_ce4286,
  author = {Unknown},
  title = {Zhou H, Xuanyuan X, Lv X, Wang J, Feng K, Chen C, Ma J, Xing D},
  year = {2023},
  doi = {10.1016/s0140-6736(23)00806-1},
  
}
DOI: 10.1016/s0140-6736(23)00806-1PubMed: 37245517

Quick Questions About This Study

The study included 7,036 stroke patients across 121 hospitals in 10 countries. This large sample size provided strong statistical power to detect meaningful differences in patient outcomes between the care bundle and usual care groups.
The care bundle targeted four key areas: lowering blood pressure below 140 mmHg, controlling blood sugar levels, reducing fever to 37.5°C or below, and reversing blood-thinning medication effects within one hour of treatment.
Patients receiving the care bundle had 14% better odds of good functional recovery compared to usual care. They also experienced 20% fewer serious adverse events, demonstrating both improved outcomes and enhanced safety.
The study included hospitals from nine low- and middle-income countries (Brazil, China, India, Mexico, Nigeria, Pakistan, Peru, Sri Lanka, Vietnam) plus one high-income country (Chile), ensuring diverse healthcare settings were represented.
Researchers tracked patient outcomes for six months after the initial stroke treatment. This follow-up period allowed them to assess long-term functional recovery using the modified Rankin scale, which measures disability levels from no symptoms to death.